GWSAF yields 1968.50% · PFE yields 6.13%● Live data
📍 GWSAF pulled ahead of the other in Year 1
Combined, GWSAF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GWSAF + PFE for your $10,000?
Gowest Gold Ltd. operates as a gold exploration and development company in Canada. The company focuses on the development of its 100% owned Bradshaw gold deposit, which is part of the North Timmins gold project located near Timmins, Ontario. It holds interest in the North Timmins Gold Project that covers 1 patented mining claim, 11 mining leases, and 56 unpatented mining claims covering an area of approximately 11,185 hectares in Evelyn, Gowan, Little, Prosser, Tully, and Wark Townships in the Timmins gold camp. The company also holds interest in the Frankfield Property, which comprise 9 mining leases covering an area of 837 hectares; and 67.7% interest in the Pipestone Property consisting of two blocks covering an area of approximately 7,577 hectares. In addition, it holds 100% interest in the Tully Property that consists of two claim blocks covering an area of approximately 2,513 hectares located in Tully Township; and the Gowest Whitney Property, which consists of nine patented claims covering an area of approximately 144 hectares located in Timmins, Ontario. The company was formerly known as Gowest Amalgamated Resources Ltd. and changed its name to Gowest Gold Ltd. in March 2011. Gowest Gold Ltd. is headquartered in Toronto, Canada.
Full GWSAF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.